C293HIV-1

Sharif Karim Sayyed1, Marzuqa Quraishi1, Satish Kumar Rajasekharan2

  • 1Amity Institute of Biotechnology, Amity University Maharashtra, Bhatan, Panvel, Navi Mumbai, Maharashtra 410206, India.

概括

一种新型化合物,C293,显示出作为HIV-1整合酶和逆转录酶的双重抑制剂的前景. 这一发现提供了一种潜在的新策略,可以对抗HIV耐药性,并改善治疗结果.